Ligand-induced downregulation of receptors for TGF-β in human osteoblast-like cells from adult donors

J. Gebken; A. Feydt; J. Brinckmann; H. Notbohm; P. K. Müller; B. Bätge

doi:10.1677/joe.0.1610503

Ligand-induced downregulation of receptors for TGF-β in human osteoblast-like cells from adult donors

J. Gebken, A. Feydt, J. Brinckmann, H. Notbohm, P. K. Müller, B. Bätge^*

^*Corresponding author for this work

25 Citations (Scopus)

Abstract

High concentrations of transforming growth factor b (TGF-β) are found in the bone matrix, reflecting a pivotal role of this growth factor in the coupling of bone resorption and formation. TGF-β strongly stimulates the synthesis of extracellular matrix proteins, but in vitro studies show an inhibitory effect on the final mineralization process, which in vivo occurs despite high concentrations of TGF-β. Little is known about how bone- forming cells respond to different concentrations of TGF-β and if they can transiently adapt receptor numbers in order to modulate cellular activity. Against this background, we studied the cell-surface expression of TGF-β receptors (TβR) I, II and III (betaglycan) on human osteoblast-like cells from adult donors, and examined the TβR presentation on these cells after a preceding exposure to TGF-β1. Affinity crosslinking studies with disuccinimidylsuberate showed the presence of all three receptor types. Preincubation with TGF-β1 markedly reduced ¹²⁵I-TGF-β1 binding in a time-dependent and dose-dependent manner and revealed a 95% reduction after an 18-h preincubation with 200 pM TGF-β1. In parallel, Scatchard analysis showed that the binding affinity did not change as a consequence of TGF-β1 preincubation. Immunoblotting analyses revealed an almost complete disappearance of immunoreactive TβR-II and TβR-III proteins after a 24-h preincubation with TGF-β1. Using semi-quantitative reverse transcription PCR, no effect of TGF-β1 on the expression of TβR-II mRNA was observed. These studies demonstrate a ligand-induced downregulation of TβRs-II and - III on human osteoblast-like cells, without any evidence for recovery within the first 24 h, both in the presence and after the removal of the ligand. The underlying mechanism appears to be based on post-transcriptional events. The results suggest that high concentrations of active TGF-β1 decrease the responsiveness of osteoblasts towards this growth factor.

Original language	English
Journal	Journal of Endocrinology
Volume	161
Issue number	3
Pages (from-to)	503-510
Number of pages	8
ISSN	0022-0795
DOIs	https://doi.org/10.1677/joe.0.1610503
Publication status	Published - 26.06.1999

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1677/joe.0.1610503

Cite this

@article{6fed7b1c0cd64b4c9b597c608ff97956,

title = "Ligand-induced downregulation of receptors for TGF-β in human osteoblast-like cells from adult donors",

abstract = "High concentrations of transforming growth factor b (TGF-β) are found in the bone matrix, reflecting a pivotal role of this growth factor in the coupling of bone resorption and formation. TGF-β strongly stimulates the synthesis of extracellular matrix proteins, but in vitro studies show an inhibitory effect on the final mineralization process, which in vivo occurs despite high concentrations of TGF-β. Little is known about how bone- forming cells respond to different concentrations of TGF-β and if they can transiently adapt receptor numbers in order to modulate cellular activity. Against this background, we studied the cell-surface expression of TGF-β receptors (TβR) I, II and III (betaglycan) on human osteoblast-like cells from adult donors, and examined the TβR presentation on these cells after a preceding exposure to TGF-β1. Affinity crosslinking studies with disuccinimidylsuberate showed the presence of all three receptor types. Preincubation with TGF-β1 markedly reduced 125I-TGF-β1 binding in a time-dependent and dose-dependent manner and revealed a 95% reduction after an 18-h preincubation with 200 pM TGF-β1. In parallel, Scatchard analysis showed that the binding affinity did not change as a consequence of TGF-β1 preincubation. Immunoblotting analyses revealed an almost complete disappearance of immunoreactive TβR-II and TβR-III proteins after a 24-h preincubation with TGF-β1. Using semi-quantitative reverse transcription PCR, no effect of TGF-β1 on the expression of TβR-II mRNA was observed. These studies demonstrate a ligand-induced downregulation of TβRs-II and - III on human osteoblast-like cells, without any evidence for recovery within the first 24 h, both in the presence and after the removal of the ligand. The underlying mechanism appears to be based on post-transcriptional events. The results suggest that high concentrations of active TGF-β1 decrease the responsiveness of osteoblasts towards this growth factor.",

author = "J. Gebken and A. Feydt and J. Brinckmann and H. Notbohm and M{\"u}ller, {P. K.} and B. B{\"a}tge",

year = "1999",

month = jun,

day = "26",

doi = "10.1677/joe.0.1610503",

language = "English",

volume = "161",

pages = "503--510",

journal = "Journal of Endocrinology",

issn = "0022-0795",

publisher = "Bioscientifica Ltd",

number = "3",

}

TY - JOUR

T1 - Ligand-induced downregulation of receptors for TGF-β in human osteoblast-like cells from adult donors

AU - Gebken, J.

AU - Feydt, A.

AU - Brinckmann, J.

AU - Notbohm, H.

AU - Müller, P. K.

AU - Bätge, B.

PY - 1999/6/26

Y1 - 1999/6/26

N2 - High concentrations of transforming growth factor b (TGF-β) are found in the bone matrix, reflecting a pivotal role of this growth factor in the coupling of bone resorption and formation. TGF-β strongly stimulates the synthesis of extracellular matrix proteins, but in vitro studies show an inhibitory effect on the final mineralization process, which in vivo occurs despite high concentrations of TGF-β. Little is known about how bone- forming cells respond to different concentrations of TGF-β and if they can transiently adapt receptor numbers in order to modulate cellular activity. Against this background, we studied the cell-surface expression of TGF-β receptors (TβR) I, II and III (betaglycan) on human osteoblast-like cells from adult donors, and examined the TβR presentation on these cells after a preceding exposure to TGF-β1. Affinity crosslinking studies with disuccinimidylsuberate showed the presence of all three receptor types. Preincubation with TGF-β1 markedly reduced 125I-TGF-β1 binding in a time-dependent and dose-dependent manner and revealed a 95% reduction after an 18-h preincubation with 200 pM TGF-β1. In parallel, Scatchard analysis showed that the binding affinity did not change as a consequence of TGF-β1 preincubation. Immunoblotting analyses revealed an almost complete disappearance of immunoreactive TβR-II and TβR-III proteins after a 24-h preincubation with TGF-β1. Using semi-quantitative reverse transcription PCR, no effect of TGF-β1 on the expression of TβR-II mRNA was observed. These studies demonstrate a ligand-induced downregulation of TβRs-II and - III on human osteoblast-like cells, without any evidence for recovery within the first 24 h, both in the presence and after the removal of the ligand. The underlying mechanism appears to be based on post-transcriptional events. The results suggest that high concentrations of active TGF-β1 decrease the responsiveness of osteoblasts towards this growth factor.

AB - High concentrations of transforming growth factor b (TGF-β) are found in the bone matrix, reflecting a pivotal role of this growth factor in the coupling of bone resorption and formation. TGF-β strongly stimulates the synthesis of extracellular matrix proteins, but in vitro studies show an inhibitory effect on the final mineralization process, which in vivo occurs despite high concentrations of TGF-β. Little is known about how bone- forming cells respond to different concentrations of TGF-β and if they can transiently adapt receptor numbers in order to modulate cellular activity. Against this background, we studied the cell-surface expression of TGF-β receptors (TβR) I, II and III (betaglycan) on human osteoblast-like cells from adult donors, and examined the TβR presentation on these cells after a preceding exposure to TGF-β1. Affinity crosslinking studies with disuccinimidylsuberate showed the presence of all three receptor types. Preincubation with TGF-β1 markedly reduced 125I-TGF-β1 binding in a time-dependent and dose-dependent manner and revealed a 95% reduction after an 18-h preincubation with 200 pM TGF-β1. In parallel, Scatchard analysis showed that the binding affinity did not change as a consequence of TGF-β1 preincubation. Immunoblotting analyses revealed an almost complete disappearance of immunoreactive TβR-II and TβR-III proteins after a 24-h preincubation with TGF-β1. Using semi-quantitative reverse transcription PCR, no effect of TGF-β1 on the expression of TβR-II mRNA was observed. These studies demonstrate a ligand-induced downregulation of TβRs-II and - III on human osteoblast-like cells, without any evidence for recovery within the first 24 h, both in the presence and after the removal of the ligand. The underlying mechanism appears to be based on post-transcriptional events. The results suggest that high concentrations of active TGF-β1 decrease the responsiveness of osteoblasts towards this growth factor.

UR - http://www.scopus.com/inward/record.url?scp=1942512225&partnerID=8YFLogxK

U2 - 10.1677/joe.0.1610503

DO - 10.1677/joe.0.1610503

M3 - Journal articles

C2 - 10334821

AN - SCOPUS:1942512225

SN - 0022-0795

VL - 161

SP - 503

EP - 510

JO - Journal of Endocrinology

JF - Journal of Endocrinology

IS - 3

ER -

Ligand-induced downregulation of receptors for TGF-β in human osteoblast-like cells from adult donors

Abstract

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this